PHARMA & MEDICAL EDUCATION

B2B Pharma Head Unmet HCP Engagement & Medical Education Platform Survey

Pharma heads evaluate, compare, and navigate HCP engagement platforms, medical education content formats, and channel reach trade-offs, so you can sharpen platform positioning, fix conversion gaps, and benchmark segmentation against peer portfolios.

Pan-India sample
Pharma Heads (Medical Affairs, Marketing Decision-Makers)
15-20 min
Talk to a Survey Consultant
Engagement friction & drop-offsIdentify where HCP engagement stalls across platform touchpoints and content formats.
Platform selection & unmet needsBenchmark unmet feature gaps, content preferences, and switching triggers by specialty segment.
TRUSTED BY LEADING BRANDS
Brand 0Brand 1Brand 2Brand 3Brand 4Brand 5Brand 6Brand 7Brand 8Brand 9Brand 10Brand 11Brand 12Brand 13Brand 14Brand 15Brand 16Brand 17Brand 18Brand 19Brand 20Brand 21Brand 22Brand 23Brand 24Brand 25Brand 26Brand 27Brand 28Brand 29Brand 30Brand 31

CONTEXT & RELEVANCE

Why run this survey now

Most Pharma Heads don't lose HCP mindshare purely on content quality. They lose it due to fragmented channel reach, misaligned medical education formats, low platform stickiness, rep-digital disconnect, and untracked engagement gaps, none of which fully show up in CRM activity logs or medical affairs dashboards.

If you are...

  • Pharma Head, HCP engagement
  • Medical Affairs platform owner
  • Commercial excellence lead
  • Brand team, specialty therapeutics
  • Digital health / omnichannel lead

You're likely facing...

  • Platform fatigue: HCP drop-off rates
  • CME vs promotional content confusion
  • Rep-digital channel attribution gaps
  • Specialty vs GP engagement mismatch
  • Medical education ROI unmeasured

This will help answer...

  • HCP platform preference by specialty
  • Engagement drop-off stage
  • Unmet medical education format needs
  • Content credibility vs commercial perception
  • Switching triggers across platforms

RESEARCH THEMES

What This Survey Investigates

Eight interconnected research themes that map the complete HCP engagement journey from initial outreach to sustained medical advocacy.

TENETS 01

Channel Reach & Gaps

  • Preferred HCP contact channels
  • Unmet outreach frequency by specialty
TENETS 02

Content Relevance & Fit

  • Scientific content gaps by therapy area
  • HCP-reported material quality issues
TENETS 03

Platform Preference & Adoption

  • Digital platform usage by HCP segment
  • Adoption barriers across rep-led touchpoints
TENETS 04

MSL Effectiveness & Gaps

  • MSL visit frequency vs. KOL expectation
  • Scientific exchange quality by account tier
TENETS 05

CME Program Impact

  • CME format preference by specialty
  • Prescribing behavior shift post-program
TENETS 06

Engagement Friction & Drop-off

  • Drop-off points in HCP engagement funnel
  • Compliance and approval cycle delays
TENETS 07

KOL Mapping & Influence

  • KOL identification criteria by therapy area
  • Peer influence reach across prescriber tiers
TENETS 08

Competitive Benchmarking

  • Competitor engagement frequency benchmarks
  • HCP perception of rival medical platforms

SAMPLING STRATEGY

Tell us about your ideal sample

Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.

Sample size
How many respondents do you need?
Not Selected
Target audience
Who should we survey?
Not Selected
Region
Which regions should we cover?
Not Selected
Segments
How should we slice the data?
Not Selected
Discuss sample plan

METHODOLOGY

Survey approach

For the B2B Pharma Head Unmet HCP Engagement and Medical Education Platform Survey, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification.

PRIMARY
Online web surveySelf-administered survey shared via email / panels to capture structured responses at scale.
Best for
1
Ranking HCP engagement channel preferences by specialty
2
Benchmarking medical education platform adoption rates
3
Comparing unmet needs across therapy areas and geographies
Deliverables
Channel preference ranking
Platform gap matrix
Specialty segment cuts
OPTIONAL
CATI (phone survey)Interviewer-led telephone interviews to reach owners who are harder to get online.
Best for
1
Senior KOLs and specialists with low digital survey participation
2
Rapid coverage across Tier 2 and Tier 3 medical markets
Deliverables
KOL coverage report
Regional engagement gaps
SELECTIVE
Face-to-faceOn-ground surveys or interviews in key industrial clusters or high-value cohorts.
Best for
1
High-prescriber cohorts requiring verified platform usage data
2
Medical conference sites and hospital cluster intercepts
Deliverables
Prescriber journey maps
Cluster engagement profiles
OPTIONAL
FGDs
Deliverables
Verbatim themes
Content concept feedback
OPTIONAL
Mixed surveysAny 4-mode combo Online + CATI + F2F + FGDs to maximise reach and representation. Mode-specific quotas and weighting for clean comparisons.
Deliverables
Unified dataset
Mode-adjusted analytics
Our Recommendation
Start with: Online web survey as the core quant layer, targeting pharma heads and medical affairs leads across therapy areas, supported by CATI for senior KOLs and specialists with low online survey participation.
Consider adding: Face-to-face interviews at high-prescriber hospital clusters and a focused FGD layer to pressure-test medical education platform concepts and refine HCP engagement messaging.

EXECUTION PROCESS

How we execute

A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.

Define the decision frame

Confirm objectives, target cohorts, geographies, and reporting cuts

Step 01

Define the decision frame

Design the instrument

Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)

Step 02

Design the instrument

Lock the questionnaire

Review wording, sequencing, LOI, and competitive context; approve final version

Step 03

Lock the questionnaire

Pilot and calibrate

Test comprehension and ease quality; refine quotas and remove friction where needed

Step 04

Pilot and calibrate

Run fieldwork

Execute collection with active quota management and feasibility controls

Step 05

Run fieldwork

Assure quality

Dedupe, attention checks, speed/consistency rules, removals with audit trail

Step 06

Assure quality

Prepare the dataset

Clean data and deliver codebook/variable definitions

Step 07

Prepare the dataset

Analyse and synthesise

Driver ranking, leakage diagnostics, pricing bands, segment insights

Step 08

Analyse and synthesise

Deliver and align

Executive deck (optional dashboard) and leadership readout with recommendations

Step 09

Deliver and align

COMMERCIAL TERMS

Request a Commercial Proposal

Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.

Select Sample Size

100

Geography

  • India
  • APAC (Singapore, Vietnam, Philippines, Indonesia, Australia, NZ, Japan, Thailand)
  • Middle East (UAE, KSA, Qatar, Bahrain, Oman, Kuwait)
  • North America (US, Canada)
  • Europe
  • Africa (South Africa, Kenya, Nigeria, Egypt, Algeria)
  • LATAM (Brazil, Mexico)

Select Mode of Survey

  • Online
  • CATI
  • Online FGD (5 people per FGD)
  • F2F

Length of the Interview

  • Select
  • 0-15
  • 16-20
  • 21-30
  • 31-45
  • 46-60
  • Custom
Indicative Estimate
  • Indian Rupee (INR)
  • United Arab Emirates Dirham (AED)
  • Afghan Afghani (AFN)
  • Albanian Lek (ALL)
  • Armenian Dram (AMD)
  • Netherlands Antillean Guilder (ANG)
  • Angolan Kwanza (AOA)
  • Argentine Peso (ARS)
  • Australian Dollar (AUD)
  • Aruban Florin (AWG)
  • Azerbaijani Manat (AZN)
  • Bosnia-Herzegovina Convertible Mark (BAM)
  • Barbadian Dollar (BBD)
  • Bangladeshi Taka (BDT)
  • Bulgarian Lev (BGN)
  • Bahraini Dinar (BHD)
  • Burundian Franc (BIF)
  • Bermudian Dollar (BMD)
  • Brunei Dollar (BND)
  • Bolivian Boliviano (BOB)
  • Brazilian Real (BRL)
  • Bahamian Dollar (BSD)
  • Bhutanese Ngultrum (BTN)
  • Botswana Pula (BWP)
  • Belarusian Ruble (BYN)
  • Belize Dollar (BZD)
  • Canadian Dollar (CAD)
  • Congolese Franc (CDF)
  • Swiss Franc (CHF)
  • Chilean Peso (CLP)
  • Chinese Yuan (CNY)
  • Colombian Peso (COP)
  • Costa Rican Colón (CRC)
  • Cuban Peso (CUP)
  • Cape Verdean Escudo (CVE)
  • Czech Koruna (CZK)
  • Djiboutian Franc (DJF)
  • Danish Krone (DKK)
  • Dominican Peso (DOP)
  • Algerian Dinar (DZD)
  • Egyptian Pound (EGP)
  • Eritrean Nakfa (ERN)
  • Ethiopian Birr (ETB)
  • Euro (EUR)
  • Fijian Dollar (FJD)
  • Falkland Islands Pound (FKP)
  • British Pound (GBP)
  • Georgian Lari (GEL)
  • Ghanaian Cedi (GHS)
  • Gibraltar Pound (GIP)
  • Gambian Dalasi (GMD)
  • Guinean Franc (GNF)
  • Guatemalan Quetzal (GTQ)
  • Guyanese Dollar (GYD)
  • Hong Kong Dollar (HKD)
  • Honduran Lempira (HNL)
  • Croatian Kuna (HRK)
  • Haitian Gourde (HTG)
  • Hungarian Forint (HUF)
  • Indonesian Rupiah (IDR)
  • Israeli New Shekel (ILS)
  • Iraqi Dinar (IQD)
  • Iranian Rial (IRR)
  • Icelandic Króna (ISK)
  • Jamaican Dollar (JMD)
  • Jordanian Dinar (JOD)
  • Japanese Yen (JPY)
  • Kenyan Shilling (KES)
  • Kyrgyzstani Som (KGS)
  • Cambodian Riel (KHR)
  • Comorian Franc (KMF)
  • South Korean Won (KRW)
  • Kuwaiti Dinar (KWD)
  • Cayman Islands Dollar (KYD)
  • Kazakhstani Tenge (KZT)
  • Lao Kip (LAK)
  • Lebanese Pound (LBP)
  • Sri Lankan Rupee (LKR)
  • Liberian Dollar (LRD)
  • Lesotho Loti (LSL)
  • Libyan Dinar (LYD)
  • Moroccan Dirham (MAD)
  • Moldovan Leu (MDL)
  • Malagasy Ariary (MGA)
  • Macedonian Denar (MKD)
  • Burmese Kyat (MMK)
  • Mongolian Tögrög (MNT)
  • Macanese Pataca (MOP)
  • Mauritian Rupee (MUR)
  • Maldivian Rufiyaa (MVR)
  • Malawian Kwacha (MWK)
  • Mexican Peso (MXN)
  • Malaysian Ringgit (MYR)
  • Mozambican Metical (MZN)
  • Namibian Dollar (NAD)
  • Nigerian Naira (NGN)
  • Nicaraguan Córdoba (NIO)
  • Norwegian Krone (NOK)
  • Nepalese Rupee (NPR)
  • New Zealand Dollar (NZD)
  • Omani Rial (OMR)
  • Panamanian Balboa (PAB)
  • Peruvian Sol (PEN)
  • Papua New Guinean Kina (PGK)
  • Philippine Peso (PHP)
  • Pakistani Rupee (PKR)
  • Polish Złoty (PLN)
  • Paraguayan Guaraní (PYG)
  • Qatari Riyal (QAR)
  • Romanian Leu (RON)
  • Serbian Dinar (RSD)
  • Russian Ruble (RUB)
  • Rwandan Franc (RWF)
  • Saudi Riyal (SAR)
  • Solomon Islands Dollar (SBD)
  • Seychellois Rupee (SCR)
  • Sudanese Pound (SDG)
  • Swedish Krona (SEK)
  • Singapore Dollar (SGD)
  • Saint Helena Pound (SHP)
  • Sierra Leonean Leone (SLL)
  • Somali Shilling (SOS)
  • Surinamese Dollar (SRD)
  • São Tomé and Príncipe Dobra (STD)
  • Syrian Pound (SYP)
  • Swazi Lilangeni (SZL)
  • Thai Baht (THB)
  • Tajikistani Somoni (TJS)
  • Turkmenistani Manat (TMT)
  • Tunisian Dinar (TND)
  • Tongan Paʻanga (TOP)
  • Turkish Lira (TRY)
  • Trinidad and Tobago Dollar (TTD)
  • New Taiwan Dollar (TWD)
  • Tanzanian Shilling (TZS)
  • Ukrainian Hryvnia (UAH)
  • Ugandan Shilling (UGX)
  • United States Dollar (USD)
  • Uruguayan Peso (UYU)
  • Uzbekistani Som (UZS)
  • Vietnamese Đồng (VND)
  • Vanuatu Vatu (VUV)
  • Samoan Tālā (WST)
  • Central African CFA Franc (XAF)
  • East Caribbean Dollar (XCD)
  • West African CFA franc (XOF)
  • CFP Franc (XPF)
  • Yemeni Rial (YER)
  • South African Rand (ZAR)
  • Zambian Kwacha (ZMW)
  • Zimbabwean Dollar (ZWL)

$0.00

+ applicable taxes

Proposal turnaround typically 24–48 hours

Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.

REFERENCE CASELETS

Reference

Real-world examples of survey work in the pharma medical education and HCP engagement space.

CASELET 1

HCP channel preference & medical content format mapping (India)

CASELET 2

Medical affairs messaging & KOL engagement gap diagnosis (India)

HCP channel preference & medical content format mapping (India)

OBJECTIVE

A specialty pharma company needed to map how cardiologists and diabetologists across Tier 1 and Tier 2 cities ranked digital CME platforms against rep-led detailing for therapeutic updates, and what drove format switching.

WHAT WE DID

Ran a structured quant survey across 280 HCPs in 6 cities, capturing platform preference rankings , content consumption frequency , session length tolerance , and accreditation value perception by specialty and practice setting.

DELIVERED

A channel preference map by specialty and city tier, a content format corridor showing optimal session length and depth by audience segment, and a ranked friction list for digital CME adoption among time-constrained specialists.
CASELET 1

HCP channel preference & medical content format mapping (India)

CASELET 2

Medical affairs messaging & KOL engagement gap diagnosis (India)

HCP channel preference & medical content format mapping (India)

OBJECTIVE

A specialty pharma company needed to map how cardiologists and diabetologists across Tier 1 and Tier 2 cities ranked digital CME platforms against rep-led detailing for therapeutic updates, and what drove format switching.

WHAT WE DID

Ran a structured quant survey across 280 HCPs in 6 cities, capturing platform preference rankings , content consumption frequency , session length tolerance , and accreditation value perception by specialty and practice setting.

DELIVERED

A channel preference map by specialty and city tier, a content format corridor showing optimal session length and depth by audience segment, and a ranked friction list for digital CME adoption among time-constrained specialists.

FREQUENTLY ASKED QUESTIONS

Common Questions

Answers to frequently asked questions about this survey mandate.

What decisions will this survey enable?

Who is the buyer vs who are the respondents?

Can we see differences between specialist physicians, general practitioners and allied health professionals?

How will you measure HCP platform preference beyond simple ratings?

Will the survey map the full HCP engagement journey and drop-offs?

Can this survey inform product and pricing strategy?

How will findings improve our HCP engagement and medical education platform adoption?

Still have questions?

Schedule a discovery call to discuss your specific needs and get a custom quote.

Book a Discovery Call